← Open Payments lookup

JESSICA WEAVER: Open Payments

NPI 1437538485 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$604 in 27 payments from 10 companies in 2025. Trend: 2023 $1,623 · 2024 $1,152 · 2025 $604

Food & beverage: $604
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation6$125
Amgen Inc.5$102
E.R. Squibb & Sons, L.L.C.4$87
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)3$64
AstraZeneca Pharmaceuticals LP3$55
Abbott Laboratories1$53
Regeneron Healthcare Solutions, Inc.2$46
Actelion Pharmaceuticals US, Inc.1$29
Merck Sharp & Dohme LLC1$28
Boehringer Ingelheim Pharmaceuticals, Inc.1$16

Products named: LEQVIO, REPATHA, CAMZYOS, LifeVest, AVEIR, EVKEEZA, WAINUA, OPSUMIT.

Industry payments across CA — which companies pay providers there.